Literature DB >> 29358316

Ras-Mediated Activation of the Raf Family Kinases.

Elizabeth M Terrell1, Deborah K Morrison1.   

Abstract

The extracellular signal-regulated kinase (ERK) cascade comprised of the Raf, MEK, and ERK protein kinases constitutes a key effector cascade used by the Ras GTPases to relay signals regulating cell growth, survival, proliferation, and differentiation. Of the ERK cascade components, the regulation of the Raf kinases is by far the most complex, involving changes in subcellular localization, protein and lipid interactions, as well as alterations in the Raf phosphorylation state. The Raf kinases interact directly with active, membrane-localized Ras, and this interaction is often the first step in the Raf activation process, which ultimately results in ERK activation and the downstream phosphorylation of cellular targets that will specify a particular biological response. Here, we will examine our current understanding of how Ras promotes Raf activation, focusing on the molecular mechanisms that contribute to the Raf activation/inactivation cycle.
Copyright © 2019 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29358316      PMCID: PMC6311149          DOI: 10.1101/cshperspect.a033746

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  109 in total

1.  Positive and negative regulation of Raf kinase activity and function by phosphorylation.

Authors:  H Chong; J Lee; K L Guan
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

2.  Discrete cytosolic macromolecular BRAF complexes exhibit distinct activities and composition.

Authors:  Britta Diedrich; Kristoffer Tg Rigbolt; Michael Röring; Ricarda Herr; Stephanie Kaeser-Pebernard; Christine Gretzmeier; Robert F Murphy; Tilman Brummer; Jörn Dengjel
Journal:  EMBO J       Date:  2017-01-16       Impact factor: 11.598

3.  Complex formation between RAS and RAF and other protein kinases.

Authors:  L Van Aelst; M Barr; S Marcus; A Polverino; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  The protein kinase KSR interacts with 14-3-3 protein and Raf.

Authors:  H Xing; K Kornfeld; A J Muslin
Journal:  Curr Biol       Date:  1997-05-01       Impact factor: 10.834

5.  Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259.

Authors:  Amardeep S Dhillon; Claire Pollock; Helge Steen; Peter E Shaw; Harald Mischak; Walter Kolch
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

6.  The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338.

Authors:  A J King; H Sun; B Diaz; D Barnard; W Miao; S Bagrodia; M S Marshall
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

7.  Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites.

Authors:  Stéphane Ory; Ming Zhou; Thomas P Conrads; Timothy D Veenstra; Deborah K Morrison
Journal:  Curr Biol       Date:  2003-08-19       Impact factor: 10.834

8.  RAF inhibitors activate the MAPK pathway by relieving inhibitory autophosphorylation.

Authors:  Matthew Holderfield; Hanne Merritt; John Chan; Marco Wallroth; Laura Tandeske; Huili Zhai; John Tellew; Stephen Hardy; Mohammad Hekmat-Nejad; Darrin D Stuart; Frank McCormick; Tobi E Nagel
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

9.  KSR, a novel protein kinase required for RAS signal transduction.

Authors:  M Therrien; H C Chang; N M Solomon; F D Karim; D A Wassarman; G M Rubin
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

10.  Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling.

Authors:  Daniel A Ritt; Daniel M Monson; Suzanne I Specht; Deborah K Morrison
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

View more
  35 in total

1.  Anionic Lipids Impact RAS-Binding Site Accessibility and Membrane Binding Affinity of CRAF RBD-CRD.

Authors:  Timothy Travers; Cesar A López; Constance Agamasu; Jeevapani J Hettige; Simon Messing; Angel E García; Andrew G Stephen; S Gnanakaran
Journal:  Biophys J       Date:  2020-06-27       Impact factor: 4.033

2.  Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma.

Authors:  Ian C MacArthur; Yi Bei; Heathcliff Dorado Garcia; Michael V Ortiz; Joern Toedling; Filippos Klironomos; Jana Rolff; Angelika Eggert; Johannes H Schulte; Alex Kentsis; Anton G Henssen
Journal:  JCI Insight       Date:  2019-04-18

3.  Polycistronic baculovirus expression of SUGT1 enables high-yield production of recombinant leucine-rich repeat proteins and protein complexes.

Authors:  Kelly Snead; Vanessa Wall; Hannah Ambrose; Dominic Esposito; Matthew Drew
Journal:  Protein Expr Purif       Date:  2022-02-04       Impact factor: 1.650

4.  Uncovering a membrane-distal conformation of KRAS available to recruit RAF to the plasma membrane.

Authors:  Que N Van; Cesar A López; Marco Tonelli; Troy Taylor; Ben Niu; Christopher B Stanley; Debsindhu Bhowmik; Timothy H Tran; Peter H Frank; Simon Messing; Patrick Alexander; Daniel Scott; Xiaoying Ye; Matt Drew; Oleg Chertov; Mathias Lösche; Arvind Ramanathan; Michael L Gross; Nicolas W Hengartner; William M Westler; John L Markley; Dhirendra K Simanshu; Dwight V Nissley; William K Gillette; Dominic Esposito; Frank McCormick; S Gnanakaran; Frank Heinrich; Andrew G Stephen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-10       Impact factor: 11.205

5.  Functional characterization of a PROTAC directed against BRAF mutant V600E.

Authors:  Ganna Posternak; Xiaojing Tang; Pierre Maisonneuve; Ting Jin; Hugo Lavoie; Salima Daou; Stephen Orlicky; Theo Goullet de Rugy; Lauren Caldwell; Kin Chan; Ahmed Aman; Michael Prakesch; Gennady Poda; Pavel Mader; Cassandra Wong; Stefan Maier; Julia Kitaygorodsky; Brett Larsen; Karen Colwill; Zhe Yin; Derek F Ceccarelli; Robert A Batey; Mikko Taipale; Igor Kurinov; David Uehling; Jeff Wrana; Daniel Durocher; Anne-Claude Gingras; Rima Al-Awar; Marc Therrien; Frank Sicheri
Journal:  Nat Chem Biol       Date:  2020-08-10       Impact factor: 15.040

6.  The road to ERK activation: Do neurons take alternate routes?

Authors:  Nadiatou Miningou; Kim T Blackwell
Journal:  Cell Signal       Date:  2020-01-13       Impact factor: 4.315

7.  Pulmonary Inflammation and KRAS Mutation in Lung Cancer.

Authors:  Phouthone Keohavong; Y Peter Di
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Kinase drug discovery 20 years after imatinib: progress and future directions.

Authors:  Philip Cohen; Darren Cross; Pasi A Jänne
Journal:  Nat Rev Drug Discov       Date:  2021-05-17       Impact factor: 112.288

Review 9.  Accessory proteins of the RAS-MAPK pathway: moving from the side line to the front line.

Authors:  Silke Pudewell; Christoph Wittich; Neda S Kazemein Jasemi; Farhad Bazgir; Mohammad R Ahmadian
Journal:  Commun Biol       Date:  2021-06-08

10.  A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation.

Authors:  Dhirendra K Simanshu; Deborah K Morrison
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.